Laboratory identity · Reviewed 2026-10-09
Shenzhen WYD Testing Service Co., Ltd. (深圳市万邑达检测技术有限公司) · Longhua District, Shenzhen, China
Legitimacy review
Waiida has a public Shenzhen testing-company website. Five retained Summit report images show purity and measured content, but their redacted client fields and supplier-directed QR codes leave issuer authentication and Summit attribution unresolved.
The website identifies Shenzhen WYD Testing Service Co., Ltd. (深圳市万邑达检测技术有限公司), with an address at Room 1101, Building C, Phase II, Lianjian Industrial Park, Huarong Road, Dalang Street, Longhua District, Shenzhen. Its English abbreviation is WYD.
The company publishes its name, Shenzhen address and testing contact; the retained images disclose detailed per-strength results.
No peptide-specific accreditation certificate or analytical scope was established. The website’s certification-service menu describes services offered; it is not evidence that its peptide measurements are accredited.
The public website emphasizes testing, certification, chemical analysis and electronics compliance. Peptide testing prices, sample acceptance, assay validation and turnaround were not established from the reviewed pages. Confirm those details with the laboratory before sending samples.
This review establishes the public service and document evidence. It includes no blind-sample proficiency study or independently measured customer-service dataset.
The report copies redact the client and manufacturer, and no specific issuer response confirms them. Document and public-source review completed October 9, 2026; no laboratory visit or blind sample submission.
The public website identifies a Shenzhen testing and certification business, WYD, and supplies its address and contact details. Its service pages emphasize product certification and chemical or electronic testing. That establishes a contactable company, separately from authentication of these peptide files.
The complete retained images cover BPC-157, semaglutide, epithalon, GHK-Cu and tesamorelin. They are dated March 12, 2026 and pair purity with measured content across several strengths. Each table must be read row by row; a multi-strength table is not one measured amount.
The inspected QR codes open dankangpeptidesfactory.com, a supplier website. No specific laboratory-hosted record was established for these report numbers and unique keys. The records therefore remain File checked.
The supplier copies black out the client and manufacturer. A Summit watermark does not establish who submitted the material or whether it matches a current Summit retail batch. The files remain available as historical evidence without receiving verified product controls.
These images show purity and content results. No endotoxin, sterility or heavy-metal result is printed in this five-file sample. The company’s broader service list cannot supply missing results for the tested peptides.
COA verification
Retain the report number and unique key, then ask the laboratory to confirm the complete report. The inspected QR codes did not reach an issuer record.
Result handling
The specific issuer file agrees on the report identifier, client, sample and results.
Reserve no-match for an explicit negative response from a functioning issuer lookup.
Retain material differences in client, compound, batch, amount or results.
An inaccessible portal leaves verification unresolved.
Outside the fixed automated checker roster; these reviews do not expand that roster.
Keep the full file and printed results visible without claiming an issuer match.
Certificate structure
Retain each complete report image; the five reviewed files contain multiple strengths in a table.
Reviewed files report purity and measured content by strength. They contain no endotoxin or sterility results.
Evidence boundaries
Review receipts
Public search record
Primary laboratory pages and complete supplier-linked certificates reviewed October 9, 2026.
Sources
Reusable integration rule: Separate file authenticity, vendor attribution, product-strength matching and analytical scope.
Frequently asked questions
Issuer confirmation needed. Waiida has a public Shenzhen testing-company website. Five retained Summit report images show purity and measured content, but their redacted client fields and supplier-directed QR codes leave issuer authentication and Summit attribution unresolved.
The public website emphasizes testing, certification, chemical analysis and electronics compliance. Peptide testing prices, sample acceptance, assay validation and turnaround were not established from the reviewed pages. Confirm those details with the laboratory before sending samples.
Peptide-specific scope not confirmed. No peptide-specific accreditation certificate or analytical scope was established. The website’s certification-service menu describes services offered; it is not evidence that its peptide measurements are accredited.
Retain the report number and unique key, then ask the laboratory to confirm the complete report. The inspected QR codes did not reach an issuer record.
The reviewed sources did not establish that vendors can purchase a passing result from Waiida. That is not an audited independence guarantee: sample selection, who pays, publication rights, blind-testing controls, and correction history still matter.
Supplier-submitted samples do not establish custody of every retail vial.
An inaccessible portal leaves verification unresolved.
Check the document
